Sophiris competitorsClear all
Sophiris's top competitors include Cantabio Pharmaceuticals, Roche, Bristol-Myers Squibb and AstraZeneca.
| Save Comparison |  Sophiris Sophiris is a Canada-based biopharmaceutical company focused on the research, development and commercialization of products for the treatment of urological diseases. |  Cantabio Pharmaceuticals Cantabio Pharmaceuticals Inc. is a biotechnology company focusing on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson’s disease (PD), Alzheimer’s disease (AD) and other related neurodegenerative diseases. |  Bristol-Myers Squibb Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious and life-threatening diseases. |  AstraZeneca AstraZeneca is a global biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. | |
Founding Date | Founding Date 2002 | Founding Date 2009 | Founding Date 1896 | Founding Date 1887 | Founding Date 1999 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations Sunnyvale, US HQ | Locations Basel, CH HQ Hydra, DZ Ricardo Rojas, AR Bella Vista, AU North Ryde, AU Sydney, AU Wien, AT see more | Locations New York, US HQ Braine L'alleud, BE Montréal, CA Montréal, CA Pudong Xinqu, CN Virum, DK Espoo, FI see more | Locations Cambridge, GB HQ Tizi Ouzou, DZ Sidi M'hamed, DZ Buenos Aires, AR Macquarie Park, AU Vienna, AT Cotia, BR see more |
Employees | Employees 6 | Employees 11 | Employees 94,4421% increase | Employees 23,3002% decrease | Employees 61,100 |
Valuation ($) | Valuation ($) 23.1 m | Valuation ($) 1.1 m | Valuation ($) N/A | Valuation ($) 75.3 b | Valuation ($) 103.9 b |
Twitter followers | Twitter followers 152 | Twitter followers 1.1 k | Twitter followers 196 k | Twitter followers 133.5 k | Twitter followers 159.4 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 96 | Number of tweets (last 30 days) 37 | Number of tweets (last 30 days) 56 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 9.6 | Average likes per tweet (last 30 days) 35.6 | Average likes per tweet (last 30 days) 12.1 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 81.25% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% |
Alexa Website Rank | Alexa Website Rank 220153 | Alexa Website Rank 872567 | Alexa Website Rank 74758 | Alexa Website Rank 170410 | Alexa Website Rank 132544 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) CHF48.1b (FY, 2015) | Revenue (est.) $22.6b (FY, 2018) | Revenue (est.) £16.9b (FY, 2018) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods CHF15.5b (FY, 2015) | Cost of goods N/A | Cost of goods £3.8b (FY, 2018) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit CHF32.7b (FY, 2015) | Gross profit N/A | Gross profit £13.1b (FY, 2018) |
Net income | Net income ($6.8m) (FY, 2018) | Net income ($2m) (FY, 2018) | Net income CHF9.1b (FY, 2015) | Net income $4.9b (FY, 2018) | Net income £1.6b (FY, 2018) |
Operating ⚠ | |||||
Drugs Approved by FDA | Drugs Approved by FDA N/A | Drugs Approved by FDA N/A | Drugs Approved by FDA 2 (Y, 2015) | Drugs Approved by FDA N/A | Drugs Approved by FDA 1 (FY, 2015) |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 8 (FY, 2016) | Phase III Trials Products 27 (FY, 2016) |
Projects in R&D Pipeline | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline 44 (FY, 2016) | Projects in R&D Pipeline 132 (FY, 2016) |
Funding | |||||
Total funding raised | Total funding raised $ 47.2m | Total funding raised N/A | Total funding raised $ 2.8b | Total funding raised $ 15.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View company profiles
Cantabio Pharmaceuticals
HQ
Sunnyvale, US
Employees
11
Cantabio Pharmaceuticals Inc. is a biotechnology company focusing on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson’s disease (PD), Alzheimer’s disease (AD) and other related neurodegenerative diseases.
View company
Roche
HQ
Basel, CH
Employees
94,442↑ 1% increase
Roche Holding is a diagnostics and pharmaceutical company.
View companyBristol-Myers Squibb
HQ
New York, US
Employees
23,300↓ 2% decrease
Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious and life-threatening diseases.
View companyAstraZeneca
HQ
Cambridge, GB
Employees
61,100
AstraZeneca is a global biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View company